Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04445909

Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in VA-ECMO Patients

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

Carbon dioxide in patients on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is eliminated via respirator as well as via the oxygenator's membrane of the ECMO machine. Consequently, monitoring of end-tidal carbon dioxide tensions is limited, which can result in marked swings towards non-physiological values. Hyper- and hypocapnia, however, can have detrimental effects on organ perfusion in a great number of patients supported with VA-ECMO. Continuous, rapidly applicable monitoring of reliable carbon dioxide measures would therefore be extremely helpful to prevent harmful deviations from the norm. The investigators therefore try to assess the accuracy and the precision of continuously measured non-invasive transcutaneous carbon dioxide partial pressures when compared with tensions determined by blood gas analysis.

Official title: Validation of Continuously Determined Transcutaneous Carbon Dioxide Partial Pressures in Patients Supported with Veno-arterial Extracorporeal Membrane Oxygenation

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

30

Start Date

2019-11-18

Completion Date

2025-12-31

Last Updated

2024-12-04

Healthy Volunteers

No

Conditions

Interventions

DEVICE

VA-ECMO

Deployment of extracorporeal membrane oxygenation cardiac assist device.

Locations (1)

Medical University of Vienna

Vienna, Austria